A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

Ambient AI systems may reduce documentation demands and allow physicians to spend more time interacting directly with ...

Nicotinamide supplementation confers a statistically significant risk reduction for melanoma in patients with a prior ...

Imsidolimab significantly improves skin clearance in patients with generalized pustular psoriasis in two phase 3 trials.

Migraine is linked to a 30% lower risk for dementia and a 42% lower risk for Alzheimer’s disease than not having migraine, a ...

Researchers hoped results from the latest trial on low-dose lithium would settle the question of lithium’s potential to ...

New research suggests a high-fat diet can turn the vagus nerve into a microbial highway, allowing gut bacteria to breach the ...

In a large screening study, Black soccer players of West African ancestry had higher rates of serious cardiac conditions than ...

Compared to routine care, stem cell-enriched autologous lipotransfer produces significantly greater improvement in orofacial ...

Global malaria cases are increasing despite vaccine progress, with funding gaps and resistance limiting the prevention and ...

A mandatory CMS pay-for-performance model aimed at boosting home dialysis and kidney transplant rates showed no meaningful ...

Use of SGLT-2 inhibitor therapy at hospital admission is associated with a 32% reduced risk for acute kidney injury in ...